Dashboard
Manage Tickers

EXAS EXACT SCIENCES CORP

Nasdaq exactsciences.com


$ 64.99 $ 1.47 (2.33 %)    

Friday, 31-Oct-2025 16:41:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.18 $ 3.02 (0.48 %)
DIA $ 475.66 $ 0.66 (0.14 %)
SPY $ 682.17 $ 2.23 (0.33 %)
TLT $ 90.32 $ -0.27 (-0.3 %)
GLD $ 368.12 $ -2.01 (-0.54 %)
$ 64.69
$ 62.81
$ 64.00 x 49
$ 65.00 x 1
$ 62.56 - $ 64.81
$ 38.81 - $ 72.83
2,423,190
na
11.97B
$ 1.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-19-2025 12-31-2024 10-K
4 11-05-2024 09-30-2024 10-Q
5 07-31-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-21-2024 12-31-2023 10-K
8 11-01-2023 09-30-2023 10-Q
9 08-01-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 02-21-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-02-2022 06-30-2022 10-Q
14 04-26-2022 03-31-2022 10-Q
15 02-22-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 07-28-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-16-2021 12-31-2020 10-K
20 10-27-2020 09-30-2020 10-Q
21 07-31-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 02-21-2020 12-31-2019 10-K
24 10-30-2019 09-30-2019 10-Q
25 07-30-2019 06-30-2019 10-Q
26 04-30-2019 03-31-2019 10-Q
27 02-21-2019 12-31-2018 10-K
28 10-30-2018 09-30-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 04-26-2018 03-31-2018 10-Q
31 02-22-2018 12-31-2017 10-K
32 10-30-2017 09-30-2017 10-Q
33 07-25-2017 06-30-2017 10-Q
34 04-27-2017 03-31-2017 10-Q
35 02-21-2017 12-31-2016 10-K
36 10-26-2016 09-30-2016 10-Q
37 07-26-2016 06-30-2016 10-Q
38 05-03-2016 03-31-2016 10-Q
39 02-24-2016 12-31-2015 10-K
40 10-30-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

earnings-preview-exact-sciences
Earnings Preview: Exact Sciences
10/31/2025 15:01:30

exact-sciences-showcases-new-data-highlighting-cologuards-success-in-boosting-cancer-screening-rates
Exact Sciences Showcases New Data Highligh...
10/27/2025 11:12:54

Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced new data being...

11-analysts-have-this-to-say-about-exact-sciences
11 Analysts Have This To Say About Exact S...
10/22/2025 14:00:38

btig-maintains-buy-on-exact-sciences-raises-price-target-to-75
BTIG Maintains Buy on Exact Sciences, Rais...
10/22/2025 12:03:35

BTIG analyst Mark Massaro maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $60 to $75.

piper-sandler-maintains-overweight-on-exact-sciences-raises-price-target-to-70
Piper Sandler Maintains Overweight on Exac...
10/08/2025 12:40:35

Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target ...

evercore-isi-group-maintains-outperform-on-exact-sciences-raises-price-target-to-68
Evercore ISI Group Maintains Outperform on...
10/07/2025 17:04:35

Evercore ISI Group analyst Vijay Kumar maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and raises the price target ...

exact-sciences-announces-publication-of-comparing-benefit-to-burden-ratios-of-endorsed-and-emerging-colorectal-cancer-screening-strategies-in-journal-of-national-cancer-institute
Exact Sciences Announces Publication Of Co...
10/07/2025 11:00:29

what-analysts-are-saying-about-exact-sciences-stock
What Analysts Are Saying About Exact Scien...
10/02/2025 19:01:38

barclays-maintains-overweight-on-exact-sciences-raises-price-target-to-65
Barclays Maintains Overweight on Exact Sci...
10/02/2025 13:56:58

Barclays analyst Luke Sergott maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target from $55 ...

peering-into-exact-sciencess-recent-short-interest
Peering Into Exact Sciences's Recent Short...
09/18/2025 13:00:58

demystifying-exact-sciences-insights-from-9-analyst-reviews
Demystifying Exact Sciences: Insights From...
09/11/2025 22:02:07

craig-hallum-maintains-buy-on-exact-sciences-raises-price-target-to-85
Craig-Hallum Maintains Buy on Exact Scienc...
09/11/2025 17:21:22

Craig-Hallum analyst Alex Nowark maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $65 to $85.

exact-sciences-launches-cancerguard-test-a-new-multi-cancer-early-detection-blood-test-that-is-now-available-as-a-laboratory-developed-test-in-us-at-689
Exact Sciences Launches Cancerguard Test, ...
09/10/2025 10:40:51

Only MCED test on-market to analyze multiple biomarker classes, enhancing early cancer detectionOffered as a laboratory-develop...

wayfair-united-therapeutics-and-ciena-are-among-the-top-10-large-cap-gainers-last-week-sep-1-sep5-are-the-others-in-your-portfolio-corrected
Wayfair, United Therapeutics, And Ciena Ar...
09/07/2025 14:30:00

These ten large-cap stocks were top performers last week. Are they a part of your portfolio?

micron-to-rally-more-than-49-here-are-10-top-analyst-forecasts-for-tuesday
Micron To Rally More Than 49%? Here Are 10...
08/12/2025 19:13:44

btig-maintains-buy-on-exact-sciences-lowers-price-target-to-60
BTIG Maintains Buy on Exact Sciences, Lowe...
08/12/2025 15:13:48

BTIG analyst Mark Massaro maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $65 to $60.

beyond-the-numbers-7-analysts-discuss-exact-sciences-stock
Beyond The Numbers: 7 Analysts Discuss Exa...
08/11/2025 13:02:28

piper-sandler-maintains-overweight-on-exact-sciences-lowers-price-target-to-60
Piper Sandler Maintains Overweight on Exac...
08/11/2025 12:18:12

Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and lowers the price target ...

top-3-health-care-stocks-that-are-preparing-to-pump-this-month
Top 3 Health Care Stocks That Are Preparin...
08/11/2025 12:01:23

evercore-isi-group-maintains-outperform-on-exact-sciences-lowers-price-target-to-64
Evercore ISI Group Maintains Outperform on...
08/08/2025 12:29:14

Evercore ISI Group analyst Vijay Kumar maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION